{
    "SPADE_UN_19485": {
        "Sequence Information": {
            "Peptide Name": "D-Ctl, D-Cateslytin, D-Chromogranin-A (344-358)",
            "Sequence": "RSMRLSFRARGYGFR",
            "Sequence Length": 15,
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Anticancer",
                "Antifungal",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [
                {
                    "uniprotId": "P05059",
                    "uniprotUrl": "http://www.uniprot.org/uniprot/P05059",
                    "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."
                },
                {
                    "uniprotId": "L8HWJ5",
                    "uniprotUrl": "http://www.uniprot.org/uniprot/L8HWJ5",
                    "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that may represent a peptide precursor."
                }
            ],
            "Literature": [
                {
                    "Title": "D-Cateslytin, a new antimicrobial peptide with therapeutic potential",
                    "Pubmed ID": "29123174 ",
                    "Reference": "Sci Rep. 2017;7:15199",
                    "Author": "Zaet A, Dartevelle P, Daouad F, Ehlinger C, Quilès F, Francius G, Boehler C, Bergthold C, Frisch B, Prévost G, Lavalle P, Schneider F, Haïkel Y, Metz-Boutigue MH, Marban C",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/29123174 "
                },
                {
                    "Title": "D-Cateslytin: a new antifungal agent for the treatment of oral Candida albicans associated infections.",
                    "Pubmed ID": "29915284",
                    "Reference": "Sci Rep. 2018;8:9235",
                    "Author": "Dartevelle P, Ehlinger C, Zaet A, Boehler C, Rabineau M, Westermann B, Strub JM, Cianferani S, Haïkel Y, Metz-Boutigue MH, Marban C",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/29915284"
                }
            ],
            "Mass": 1860.15,
            "PI": 12.0,
            "Net Charge": 5,
            "Hydrophobicity": -0.87,
            "Frequent Amino Acids": "RFG",
            "Absent Amino Acids": "CDEHIKNOPQTUVW",
            "Basic Residues": 5,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 5,
            "Polar Residues": 10,
            "Positive Residues": 5,
            "Negative Residues": 0,
            "SPADE ID": "SPADE_UN_19485",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_19485",
                    "Similarity": 1.0,
                    "Sequence": "RSMRLSFRARGYGFR"
                },
                {
                    "SPADE_ID": "SPADE_N_02437",
                    "Similarity": 0.8,
                    "Sequence": "SSMKLSFRARAYGFRGPGPQL"
                },
                {
                    "SPADE_ID": "SPADE_N_09833",
                    "Similarity": 0.8,
                    "Sequence": "SSMKLSFRARAYGFRGPGLQL"
                }
            ],
            "Hemolytic Activity": "Human erythrocytes:-=NA,Human gingival fibroblasts:-=NA",
            "Target Organism": "Escherichia coli ATCC 25922(MIC=8µg/ml),Escherichia coli K-12(MIC=8.4µg/ml),Fusobacterium nucleatum ATCC 49256(MIC=22µg/ml),Prevotella intermedia ATCC 49046(MIC=10µg/ml),Parvimonas micra ATCC 33270(MIC=23µg/ml),Staphylococcus aureus ATCC 25923(MIC=24µg/ml),Staphylococcus aureus MR(MIC=18µg/ml),Human colon adenocarcinoma Caco-2(no activity data),Candida albicans ATCC 10231(MIC=5.5µg/ml)"
        }
    }
}